Blog

UCSF First in State to Provide FDA-Approved CAR-T for Pediatric Cancer Patients – UCSF News Services


Winchester Herald Chronicle

UCSF First in State to Provide FDA-Approved CART for Pediatric Cancer Patients
UCSF News Services
CAR-T represents a radically different way of treating cancer. It entails filtering Tcells from the patient's blood and reprogramming them to harbor a “chimeric antigen receptor,” or CAR, that zeroes in on cancer and develops millions of copies of the
Monroe Carell Jr. Children's Hospital at Vanderbilt to offer new cutting-edge treatment for type of pediatric leukemiaWinchester Herald Chronicle



all 2 news articles »

2017-09-19 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.